Middle East & Africa Molecular Point of care Testing (Using NAAT) Market to 2032
Overview
The Middle East & Africa Molecular Point of care Testing (Using NAAT) Market is expected to reach a 3.78 USD Billion by 2032 and is projected to grow at a CAGR of 9.31% from 2025 to 2032.
Revenue, 2024 (USD Billion)
2.17
Forecast, 2032 (USD Billion)
3.78
CAGR, 2024 - 2032
9.31%
Report Coverage
Middle East & Africa
Middle East & Africa Molecular Point of care Testing (Using NAAT) Market 2018-2032 USD Billion
Middle East & Africa Molecular Point of care Testing (Using NAAT) Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 2.17 USD Billion
- Projected Market Size (2032): 3.78 USD Billion
- CAGR (2025-2032): 9.31%
Key Findings of Middle East & Africa Molecular Point of care Testing (Using NAAT) Market
- The Middle East & Africa Molecular Point of care Testing (Using NAAT) Market was valued at 2.17 USD Billion in 2024.
- The Middle East & Africa Molecular Point of care Testing (Using NAAT) Market is likely to grow at a CAGR of 9.31% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Prescription-Based Testing in Mode of Testing Segment accounted for the largest share of the market with a revenue of 2.05 USD Billion
- The fastest growing segment Direct Sales in Distribution Channel Segment grew Fastest with a CAGR of 10.90% during the forecast period from 2024 to 2032.
Middle East & Africa Molecular Point of care Testing (Using NAAT) Market Scope
Middle East & Africa Molecular Point of care Testing (Using NAAT) Market Segmentation & Scope
Distribution Channel
- Online Sales
- Third Party Distributor
- Direct Sales
Mode of Testing
- OTC Testing
- Prescription-Based Testing
End User
- Assisted Living Facilities
- Homecare
- Others
- Ambulatory Center
- Clinics
- Hospital
- Laboratories
Indication
- Others
- Gastrointestinal Tract Infections Testing
- Sexually Transmitted Infection (STI) Testing
- Respiratory Infections Testing
Product
- Instruments
- Consumables & Reagents
Middle East & Africa Molecular Point of care Testing (Using NAAT) Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2022 |
| Unit | Revenue in USD Billion |
| Market Value in 2024 | 2.17 USD Billion |
| Market Value in 2032 | 3.78 USD Billion |
| CAGR (2025-2032) | 9.31% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Distribution Channel, Mode of Testing, End User, Indication, Product |
Regional Insights:
-
Leading Market (2024-2032): Middle East & Africa, leading in terms of revenue 2.17 USD Billion in 2024
- Key Country: Saudi Arabia, leading in terms of revenue with value of 729.79 USD Million in 2024.
Segments and Scope
-
Middle East & Africa Molecular Point of care Testing (Using NAAT) Market to 2032, By Distribution Channel
- Direct Sales is the largest segment in Middle East & Africa Molecular Point of care Testing (Using NAAT) Market to 2032 with a revenue of 1.35 USD Billion in the year 2024.
- Direct Sales is the Fastest growing segment in Middle East & Africa Molecular Point of care Testing (Using NAAT) Market to 2032 with a Growth rate of 10.90 % in forecast period 2025-2032.
-
Middle East & Africa Molecular Point of care Testing (Using NAAT) Market to 2032, By Mode of Testing
- Prescription-Based Testing is the largest segment in Middle East & Africa Molecular Point of care Testing (Using NAAT) Market to 2032 with a revenue of 2.05 USD Billion in the year 2024.
- Prescription-Based Testing is the Fastest growing segment in Middle East & Africa Molecular Point of care Testing (Using NAAT) Market to 2032 with a Growth rate of 9.61 % in forecast period 2025-2032.
-
Middle East & Africa Molecular Point of care Testing (Using NAAT) Market to 2032, By End User
- Laboratories is the largest segment in Middle East & Africa Molecular Point of care Testing (Using NAAT) Market to 2032 with a revenue of 1.59 USD Billion in the year 2024.
- Laboratories is the Fastest growing segment in Middle East & Africa Molecular Point of care Testing (Using NAAT) Market to 2032 with a Growth rate of 10.10 % in forecast period 2025-2032.
-
Middle East & Africa Molecular Point of care Testing (Using NAAT) Market to 2032, By Indication
- Respiratory Infections Testing is the largest segment in Middle East & Africa Molecular Point of care Testing (Using NAAT) Market to 2032 with a revenue of 1.38 USD Billion in the year 2024.
- Respiratory Infections Testing is the Fastest growing segment in Middle East & Africa Molecular Point of care Testing (Using NAAT) Market to 2032 with a Growth rate of 10.44 % in forecast period 2025-2032.
-
Middle East & Africa Molecular Point of care Testing (Using NAAT) Market to 2032, By Product
- Consumables & Reagents is the largest segment in Middle East & Africa Molecular Point of care Testing (Using NAAT) Market to 2032 with a revenue of 1.69 USD Billion in the year 2024.
- Consumables & Reagents is the Fastest growing segment in Middle East & Africa Molecular Point of care Testing (Using NAAT) Market to 2032 with a Growth rate of 9.55 % in forecast period 2025-2032.
Middle East & Africa Molecular Point of care Testing (Using NAAT) Market Company Share Analysis
| Company Name |
|
||
| Thermo Fisher Scientific Inc. | |||
| Abbott | |||
| Hologic, Inc. | |||
| Danaher | |||
| F. Hoffmann-La Roche Ltd. | |||
Middle East & Africa Molecular Point of care Testing (Using NAAT) Market Geographical Sales Distribution, 2018-2032 USD Billion
Middle East & Africa Molecular Point of care Testing (Using NAAT) Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The Middle East & Africa Molecular Point of care Testing (Using NAAT) Market is segmented based on Segmentation Distribution Channel, Mode of Testing, End User, Indication, Product.
Middle East & Africa Molecular Point of care Testing (Using NAAT) Market was valued at USD 2.17(Revenue in USD Billion) in 2022.
Middle East & Africa Molecular Point of care Testing (Using NAAT) Market is projected to grow at a CAGR of 9.31% during the forecast period of 2024 to 2032.
The Prescription-Based Testing segment is expected to dominate the Middle East & Africa Molecular Point of care Testing (Using NAAT) Market, holding a largest market share of 2.05 USD Billion in 2024
Coming Soon....
Middle East & Africa Molecular Point of care Testing (Using NAAT) Market Scope
Middle East & Africa Molecular Point of care Testing (Using NAAT) Market Segmentation & Scope
Distribution Channel
- Online Sales
- Third Party Distributor
- Direct Sales
Mode of Testing
- OTC Testing
- Prescription-Based Testing
End User
- Assisted Living Facilities
- Homecare
- Others
- Ambulatory Center
- Clinics
- Hospital
- Laboratories
Indication
- Others
- Gastrointestinal Tract Infections Testing
- Sexually Transmitted Infection (STI) Testing
- Respiratory Infections Testing
Product
- Instruments
- Consumables & Reagents
Frequently Asked Questions
The Middle East & Africa Molecular Point of care Testing (Using NAAT) Market is segmented based on Segmentation Distribution Channel, Mode of Testing, End User, Indication, Product.
Middle East & Africa Molecular Point of care Testing (Using NAAT) Market was valued at USD 2.17(Revenue in USD Billion) in 2022.
Middle East & Africa Molecular Point of care Testing (Using NAAT) Market is projected to grow at a CAGR of 9.31% during the forecast period of 2024 to 2032.
The estimated market value of the Middle East & Africa Molecular Point of care Testing (Using NAAT) Market for final year is USD 3.78 (USD Billion).
Middle East & Africa Molecular Point of care Testing (Using NAAT) Market Company Profiling
Frequently Asked Questions
The Middle East & Africa Molecular Point of care Testing (Using NAAT) Market is segmented based on Segmentation Distribution Channel, Mode of Testing, End User, Indication, Product.
Middle East & Africa Molecular Point of care Testing (Using NAAT) Market was valued at USD 2.17(Revenue in USD Billion) in 2022.
Middle East & Africa Molecular Point of care Testing (Using NAAT) Market is projected to grow at a CAGR of 9.31% during the forecast period of 2024 to 2032.
The estimated market value of the Middle East & Africa Molecular Point of care Testing (Using NAAT) Market for final year is USD 3.78 (USD Billion).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.